Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pfizer's Plan To Establish A $6bn Migraine Franchise

Dec 14 2022

• By Jessica Merrill

amplifier — Pfizer is looking to amp up the launch of Nurtec ODT • Source: Shutterstock

Related Content

Pfizer To Put Big Marketing Muscle Behind Migraine With Biohaven Purchase

May 10 2022

Pfizer Lays Out A Growth Plan To Offset $17bn In Coming Exclusivity Losses

Dec 13 2022

Related Companies

Pfizer Inc.

Biohaven Pharmaceutical Holding Company Ltd.

Amgen, Inc.

Eli Lilly and Company

Additional Topics

Advertising, Marketing & Sales Business Strategies Commercial Launches Neurology BioPharmaceutical

More from Neurological

More from Therapeutic Category

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.